| CASE REPORT |
|
| Year : 2020 | Volume
: 13
| Issue : 3 | Page : 146-148 |
|
|
Intravitreal aflibercept treatment for choroidal neovascularization secondary to laser pointer
Ali Keles1, Suleyman Korhan Karaman2
1 Department of Ophthalmology, Cizre State Hospital, Sirnak, Turkey
2 Department of Ophthalmology, Ulucanlar Eye Training and Research Hospital, Ankara, Turkey
Correspondence Address:
Dr. Ali Keles
Department of Ophthalmology, Cizre State Hospital, 73200, Sirnak
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ojo.OJO_10_2019
|
|
|
A 15-year-old male was presented with blurred vision in his right eye for 2 weeks. The patient had a history of looking with the right eye for 5–6 s at a distance of 20 cm from green laser beam (class 3a, 5 mW, 532 nm). Dilated fundus examinations revealed a yellow lesion in the right eye, resulting in loss of foveal reflection at the fovea. Fundus fluorescein angiography (FFA) images and spectral-domain optical coherence tomography (OCT) scans were compatible with active classic choroidal neovascularization (CNV). A single dose of intravitreal aflibercept was performed to the right eye, and at the 1st month after the injection, the best-corrected visual acuity improved to 20/100 from 20/200. FFA showed staining of the scar with no leakage, and OCT revealed scar formation. At the follow-up visits, during 38-month follow-up, no CNV activity was observed. Intravitreal aflibercept may be an appropriate treatment option in cases with laser pointer injury-induced CNV.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
